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3,4-Dichloroisocoumariin (3,4-DCI) is a highly reactive, mechanism-based inhibitor of serine proteases. We show here that glycogeu phosphorylase 
b is also inactivated by this inhibitor, in a mechanism that parallels the in~tivation of serine proteases, but involving multiple sites of covalent 
modification. Such a process may compromise studies in which 3,4-DC1 is used to arrest proteolysis of a second native protein which may itself 
be modified. 
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1. INTRODUCTION 
Limited proteolysis of native enzymes often requires 
rapid and irreversible inactivation of the protease for 
subsequent analysis of the products of the digestion. 
Several strategies are available, including denaturation 
of the reaction mixture, use of an immobilis~ pro- 
tease, removal of the protease by an immobilised in- 
hibitor or addition of a reversible, and preferably 
irreversible inhibitor [I]. 
3,4-Dic~oroisocoumarin (3,4-DCI) was designed as 
a general mechanism-based serine protease inhibitor 
capable of inactivating most elastase-like, 
chymotrypsin-like and trypsin-like proteases 121. Inac- 
tivation involves the acylation of an active site serine by 
3,4-DCI, concurrent with isocoumarin ring opening [3] 
(Fig. 1). 3,4-DC1 has several attractive features: it is an 
easily handled crystalline material, is stable for months 
in organic solvents uch as DMSO, is reasonably stable 
in aqueous media, is generally much more reactive 
towards serine proteases than phenylmethanesulpho- 
nylfluoride and is far less toxic than di-isopropyl- 
phosphotluoridate. Thus, 3,4-DC1 is of value in the 
prevention of undesirable proteolysis due to serine pro- 
teases 121 and the ~h~acterisation f the role of serine 
proteases in biological processes [3]. 
However, the usefulness of 3,CDCI in such roles 
depends critically upon 3,4-DC1 possessing high activi- 
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ty towards serine proteases but very low activity 
towards other enzymes and cellular constituents. It has 
been reported that 3,CDCI does not react with the thiol 
protease papain, the metalloprotease leucine 
~ino~ptid~e or Blactamase 121. For studies on 
limited proteolysis of glycogen phosphorylase b in 
vitro, the need for rapid inactivation of the protease, 
and instability of 3,4-DC1 in aqueous media meant hat 
it was necessary touse relatively high concentrations of 
the inhibitor. Under such conditions, we have noted 
that glycogen phosphorylase b is itself susceptible toin- 
activation by 3,4_DCI. 
2. MATERIALS AND METHODS 
We purchased the following chemicals from the sources indicated: 
pure rabbit skeletal muscle glycogen phospho~lase b (University of 
Dundee); 3,4dichloroisocoumarin, adenosine-5 ‘-monophosphate 
(AMP), glucose-l-phosphate (BCL, Lewes, East Sussex); glycogen 
type II from oyster, ammonium metavanadate, pyrophosphate 
(Sigma Chemical Co., Poole, Dorset). All other chemicals were of 
analytical grade. 
2.2. G&cogen pho~phoryl~ b asroy 
Phosphoryl~e b activity was assayed in the direction of glycogen 
synthesis and inorganic phosphate release using a modification of the 
method of Carney et al. [4]. The sample to be assayed was first 
diluted using 0.1 M maleate buffer, pH 6.8. The diiuted sample 
(10~1) was added to 10,el buffered substrate (0.15 M 
glucose-I-phosphate, 2.0 mM AMP, 2% (w/v) glycogen, 0.1 M 
maleate, pH 6.8) in a 1.5 ml micr~n~fuge tube previously 
equilibrate to 3O*C. After incubation for If min at 3O”C, 0.98 ml 
colour reagent (2 mM ammonium metavanadate, 0.57 mM am- 
monium molybdate, 0.14 M HCI; [S]) was added. The absorbance of 
the reaction mixtures at 310 nm was measured against a colour 
reagent blank. The assay is linear to 50 nkat (nmol/s) pbospho~l~e 
b. 
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Fig. 1. Reaction of 3,4-DC1 with serine proteases (after [3]). 
2.3. ~n~t~yatto~ p~osp~~ryl~e b by 3,4-DC1 
Phospho~l~e b was diluted from a glycerol stock (100 mglml) to 
0.5 mg/ml in 50 mM pyrophosphate buffer, pH 7.4. 3,4-DC1 was 
added from a DMSG stock (50 mM) such that the final concentration 
was between 100 and 5OOpM. At times thereafter, samples were 
removed and assayed for residual phosphorylase b activity. Control 
incubations included enzyme in the presence or absence of solvent. In 
other experiments, the absorbance of the reaction mixture was 
monitored at 325 nm to monitor the ring opening due to 3,4-DC1 
reaction. The stoichiometry of the modification was determined us- 
ing a molar extinction coefficient of 3670 M-i .cm-’ after correction 
for the non-specific hydrolysis of 3,4-DCI. In other incubations, 
samples were removed and resolved by anion-exchange 
chromatography. 
2.4. Anion-exchange chromatography 
Samples of phosphoryl~e B, and phospho~lase b inactivated with 
3,4_DCI were filtered through a 0.22 pm filter before application to 
a 1.0 ml Mono-Q column previously equilibrated in 10 mM 
pyrophosphate buffer, pH 7.4. A linear gradient of O-1 M NaCl in 
the same buffer was used to elute phosphorylase b and modified 
species. The eluate was monitored at 280 rim. 
3. RESULTS AND DISCUSSION 
Phosphorylase b activity is completely stable for 
120 min under the conditions described, in both the 
absence and presence of DMSO. However, addition of 
3,4-DC1 leads to rapid inactivation of the enzyme. The 
reaction is dependent on the concentration of 3,4-DC1 
but cannot be analysed as a simple first-order process 
(Fig. 2). When simple exponential decay curves were 
fitted by non-linear regression [6], the sign and 
magnitude of the residuals correlated with progress 
through the reaction, implying that the inactivation 
might be considered as a sum of several exponential 
events, consistent with multiple reaction sites. 3,4-DCI- 
inactivated phosphorylase b was analysed by sodium 
dodecyl sulphate polyacryl~de gel electrophoresis 
under which conditions it ran as a single protein band 
(ME = 97.4 kDa) even after complete loss of activity 
(results not shown). 
It was likely that 3,4-DC1 was acting as an inac- 
tivatorlinhibitor of phosphorylase b, a reaction that 
could involve acylation/ring opening by the same 
mechanism as for inhibition of serine proteases. To test 
this, we monitored the long wavelength absorption 
peak at 325 nm which is associated with the 
isocoumarin ring system (Fig. 3). Upon ring opening, 
the absorbance at 325 nm is reduced to negligible levels 
during serine protease inactivation [2]. The change in 
absorption at 325 nm can also be used to define the 
lo- 
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Fig. 2. Inactivation of phosphorylase b by 3,4-DCI. Glycogen 
phosphorytase b (0.5 mg/ml) was incubated in 50 mM 
pyrophosphate buffer, pH 7.4, in the presence of 100,~M (m), 
5OOcM (0) 3,4-DC1 or in the presence of solvent alone (5% (v/v) 
DMSO; 0). At suitable times samples were removed and assayed for 
residual glycogen phosphorylase b activity. Data are presented as 
individual values from duplicate experiments. Simple first-order 
exponential equations (At = AOCXP( - kt)) were fitted to the data and 
the residuals for the inactivation reactions for IOOtM (B) and 
5OOpM (0) 3,4-DC1 are shown (inset). 
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Fig. 3. Stoichiometry of modification of phosphorylase t, by 
3,4-DCI. Cilycogen phosphorylase b (0.5 mg/ml) was incubated in 
50 mM pyrophosphate buffer, pH 7.4, in the presence of 100 PM (m) 
3,4-DC1 or in the presence of solvent alone. The rate of inactivation 
of phosphorylase b was assayed as described previously. At the same 
time, a parallel incubation was monitored at 325 nm to measure ring- 
opening of 3,4-DC1 to derive the stoichiometry of modification of 
phosphorylase b (A). This value was correct;d for the non-specific 
hydrolysis of inhibitor during the reaction by comparison with a 
reagent blank. Data are presented as mean + range for a duplicate set 
of experiments. 
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Fig. 4. Covalent modification of phosphorylase & by 3,4-DCI. Gfycogen phosphorylase & (0.5 mgfml) was incubated with 500 pM 3,4-DCI. At 
suitable times, samples were removed and separated by chromatography at 1.0 ml/min on Mono-Q anion-exchange media. The gradient (not 
shown for clarity) was as follows: O-2.5 min: 0% B; 2.5-7.5 min: O-100% B linear; 7.5-9.5 min: 100% B; 9.5-10 min: 100-O% B linear. Buffer 
A was 10 mM pyrophosphate buffer, pH 7.4, buffer B was 10 mM pyrophosphate buffer, 1.0 M NaCI, pH 7.4. Absorbance was monitored at 
280 nm. Two solvent artefacts that were present in all traces, including blank runs, have been omitted for clarity. 
stoichiometry of modification and yield data on the 
specificity of the reaction. 
The reaction of 3,4-DC1 with phosphorylase b was 
estimated by monitoring the changes in the absorbance 
of the reaction mixture at 325 nm which correlates with 
isocoumarin ring opening. Loss of absorbance at 
325 nm due to spontaneous hydrolysis was subtracted 
from change in the absorbance at 325 nm in the 
presence of phosphorylase b to estimate the 
stoichiometry of 3,4-DC1 modification. At 100 pM 
3,4-DCI, inactivation proceeds over a 2 h period, and 
over the same period, one mol of phosphorylase b 
monomer interacts with approx. 5-6 mol equivalent of 
3,4-DCI. Multiple sites of modification are consistent 
with the kinetics of inactivation (Fig. 2). Examination 
of the early stages of the reaction indicated that the 
second-order rate constant for reaction between 
phosphorylase b and 3,4-DC1 was approx. 
3.4 M-i *s-r; substantially lower than for the serine 
proteases (human leucocyte elastase: 9820, bovine tryp- 
sin: 198, human leucocyte cathepsin G: 28 mM-* -s-I 
[2]). There are several weak nucleophilic sites on 
phosphorylase b that react with 3,4-DC1 and which 
lead to progressive loss of activity. 
The multiple modification of phosphorylase t, by 
3,4-DC1 should introduce a number of anionic sites as 
a consequence of acylation by the open-ring form of 
the inhibitor. To test this, the phosphorylase b 
derivatives were resolved by Mono-Q FPLC (Fig. 4). 
Unmodified phosphorylase b did not bind Mono-Q 
under these buffer conditions and was eluted in 2 min. 
After incubation of phosphorylase B with 3,4-DCI, the 
phosphorylase b peak was reduced and new peaks were 
eluted at higher salt concentrations, consistent with an 
increasingly anionic character for phosphoryl~e b. 
This implies multiple sites of covalent modification of 
phosphorylase b, consistent with the stoichiometry of 
modification (Fig. 3). 
The inactivation of glycogen phosphorylase b in 
vitro, involving multiple sites of weak reactivity, is 
more complex than that between 3,4-DC1 and serine 
proteases. Since phosphorylase b possesses no special 
features that one might expect to promote interaction 
with a mechanism-based serine protease inhibitor, 
3,4-DC1 may also be capable of interacting with many 
other proteins and perhaps even other macromolecules. 
This would be particularly apparent if a high concen- 
tration of 3,4-DC1 was used to elicit a rapid inactiva- 
tion, to compensate for the instabiiity of the inhibitor 
in some buffer systems, or to inactivate weakly-reactive 
proteases. Although 3,4-DC1 is an effective serine pro- 
tease inhibitor, we caution that examination of the ef- 
fect of this inhibitor on other macromolecular 
components of an experimental system would be 
prudent. 
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